---
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/264969270.md"
description: "Novo Nordisk AS stated that, in light of its commitment to financial discipline and shareholder value, the company will not increase its acquisition offer for Metsera"
datetime: "2025-11-08T08:29:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264969270.md)
  - [en](https://longbridge.com/en/news/264969270.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264969270.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/264969270.md) | [繁體中文](https://longbridge.com/zh-HK/news/264969270.md)


# 

Novo Nordisk AS stated that, in light of its commitment to financial discipline and shareholder value, the company will not increase its acquisition offer for Metsera

### 相关股票

- [Metsera (MTSR.US)](https://longbridge.com/zh-CN/quote/MTSR.US.md)
- [Novo Nordisk AS (NVO.US)](https://longbridge.com/zh-CN/quote/NVO.US.md)

## 相关资讯与研究

- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/zh-CN/news/280694583.md)
- [BREAKINGVIEWS-Novo Nordisk is Denmark’s big little problem: podcast](https://longbridge.com/zh-CN/news/280570178.md)
- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/zh-CN/news/281206892.md)
- [Novo Nordisk A/S Approves Final Dividend for 2025, Payable in March 2026](https://longbridge.com/zh-CN/news/280694679.md)
- [Novo Nordisk Updates Articles of Association and Capital Increase Mandate](https://longbridge.com/zh-CN/news/280807928.md)